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Innate immune responses have been shown to inﬂuence brain development and function.
Dysregulation of innate immunity is signiﬁcantly associated with psychiatric disorders
such as autism spectrum disorders and schizophrenia, which are well-known neurode-
velopmental disorders. Recent studies have revealed that critical players of the innate
immune response are expressed in neuronal tissues and regulate neuronal function
and activity. For example, Sarm1, a negative regulator that acts downstream of Toll-
like receptor (TLR) 3 and 4, is predominantly expressed in neurons. We have previously
shown that Sarm1 regulates neuronal morphogenesis and the expression of inﬂammatory
cytokines in the brain, which then affects learning ability, cognitive ﬂexibility, and social
interaction. Because impaired neuronal morphogenesis and dysregulation of cytokine
expression may disrupt neuronal activity, we investigated whether Sarm1 knockdown
affects the synaptic responses of neurons.We here show that reduced Sarm1 expression
impairs metabotropic glutamate receptor (mGluR)-dependent long-term depression (LTD)
formation but enhances N -methyl-D-aspartate receptor (NMDAR)-dependent long-term
potentiation production in hippocampal CA1neurons.The expression levels of post-synaptic
proteins, including NR2a, NR1, Shank1 and Shank3, are also altered in Sarm1 knockdown
mice, suggesting a role for Sarm1 in themaintenance of synaptic homeostasis.The addition
of a positive allosteric modulator of mGluR5, CDPPB, ameliorates the LTD defects in
slice recording and the behavioral deﬁcits in social interaction and associative memory.
These results suggest an important role for mGluR5 signaling in the function of Sarm1. In
conclusion, our study demonstrates a role for Sarm1 in the regulation of synaptic plasticity.
Through these mechanisms, Sarm1 knockdown results in the impairment of associative
memory and social interactions in mice.
Keywords: autism, CDPPB, innate immunity, long-term potentiation, long-term depression, metabotrophic
glutamate receptor, N -methyl-D-aspartate receptor
INTRODUCTION
Sarm1 is an evolutionarily conserved adaptor protein that con-
tains, from the N- to C-terminal region, HEAT/Armadillo motifs,
sterile alpha motifs (SAMs) and a Toll/interleukin-1 receptor (Tir)
domain. The Tir domain provides Sarm1 with unique func-
tion as a negative regulator of the Toll-like receptor (TLR) 3
and 4 signaling pathways through interaction with TIR-domain-
containing adapter-inducing interferon-β (TRIF; Carty et al.,
2006). Although Sarm1 was originally identiﬁed in peripheral
immune responses (Carty et al., 2006), Sarm1 is predominantly
expressed in the brain by neurons (Kim et al., 2007; Chen et al.,
2011; Lin et al., 2014). Sarm1 modulates TNF-α production in
the brainstem to restrict viral infection (Szretter et al., 2009).
Even in the absence of an immune challenge, knockdown of
Sarm1 in mice can alter the expression of inﬂammatory and
antiviral cytokines in the brain (Lin et al., 2014), suggesting a
neuron-autonomous effect of Sarm1 on cytokine expression. In
addition to innate immunity, our previous studies have revealed
that Sarm1 participates in neuronal morphogenesis. Through
the ASK1-MKK-JNK pathway, Sarm1 can inﬂuence microtubule
stability and regulate neuronal polarity, axonal outgrowth and
dendritic arborization (Chen et al., 2011). Analysis of trans-
genic Sarm1 knockdown mice also demonstrates that Sarm1
deﬁciency reduces dendritic arborization and brain size in vivo
(Chen et al., 2011).
Aberrant immune responses in the brain and impaired neu-
ronal morphogenesis are both involved in the pathogenesis of
neuropsychiatric diseases. Our previous study showed that Sarm1
regulates neuronal morphogenesis (Chen et al., 2011). In addition,
IL-1ß and TNF-α, the inﬂammatory cytokines regulated by Sarm1
(Lin et al., 2014), have been found to regulate synaptic plastic-
ity (Del Rey et al., 2013; Gruber-Schoffnegger et al., 2013). Taking
consideration with several other lines of evidence, Sarm1 is likely
associated with neurodevelopmental disorders. First, the human
Sarm1 gene is located at chromosome 17q11 (17:26,698,987-
26,728,065), which is within the autism susceptibility locus
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6 (Auts6, OMIM%609378, 17:24,000,000-31,800,000). Second,
reduced Sarm1 protein levels in the mid-frontal cortex were
reported in patients with autism (Azhagiri et al., 2009; Pardo
et al., 2009). Finally, the behavioral analysis of Sarm1 knockdown
mice also shows intellectual disability, impaired social behav-
iors and cognitive inﬂexibility (Lin and Hsueh, 2014). These
behavioral defects resemble the characteristics of patients with
autism.
In this study, we further investigate the detailed mechanism
associated with the behavioral deﬁcits in transgenic Sarm1 knock-
down mice. A series of electrophysiology studies were thus
performed to analyze Sarm1 knockdown mice. We found that
metabotropic glutamate receptor (mGluR)-dependent long-term
depression (LTD) is impaired and that N-methyl-D-aspartate
receptor (NMDAR)-dependent long-term potentiation (LTP) is
enhanced in Sarm1 knockdown mice. Moreover, pharmaceutical
treatments that aimed to correct the synaptic plasticity were able
to improve the animals’ behavioral defects. Our study suggests
that Sarm1 regulates electrophysiological responses through the




Hippocampal neurons were cultured on a coverslip at a den-
sity of 2 x 105, and they were transfected with a Sarm1 shRNA
construct (Sarm1i) or a pSuper.neo+GFP vector control (Chen
et al., 2011) at six days in vitro (DIV) using calcium phosphate
precipitation (Chen and Hsueh, 2012). On DIV9, the neurons
were washed with 1 ml of 1x Hank’s balanced salt solution
(HBSS; 14025-092, Invitrogen) and then incubated with 2 μM
Fura-2, AM (F-14185, Invitrogen) in HBSS for 40 min at 37◦C.
Before recording calcium imaging, the cells were washed three
times with HBSS to remove excess Fura-2, and then, the cells
were transferred to the recording chamber. The images were
recorded using an Inverted Fluorescent microscope (Axiovert 200,
Carl Zeiss) equipped with a 20 × /NA:0.75/WD 0.6 mm objec-
tive lens and MetaFlour Analyst softwares for acquisition and
analysis. The excitation wavelengths of Fura-2 and Fura2-Ca2+
complex are 380 nm and 340 nm, respectively. The Ca2+ sig-
nal in soma was monitored. The images were taken every 2 s to
measure the emission signals. The 340/380 nm excitation ratio
was calculated for the indicated intracellular Ca2+ concentra-
tion. After recording a baseline, 50 μM of glutamate in HBSS
was continuously perfused into the recording chamber to trig-
ger excitatory responses. The entire Ca2+ imaging was separated
into the baseline, rising and steady phases. The 340/380 ratio in
the last 20 cycles (40 s) was also subtracted from the baseline
340/380 ratio to indicate the synaptic activation upon glutamate
treatment.
GOLGI STAINING AND MORPHOMETRY OF DENDRITIC SPINES
The details for the Golgi staining have been described previously
(Chen et al., 2011; Wang et al., 2011). Golgi impregnated hip-
pocampal CA1 neurons were captured using a Zeiss AxioImager-
Z1microscope equippedwith anAxioCamHRsystem (Carl Zeiss),
a 63 × /1.4 oil (Plan-APO, Carl Zeiss) objective and AxioVision
software (Carl Zeiss). All of the z-stack images from each neuron
were projected into a single panel by Auto-Montage Pro software
(Synoptics Ltd). The number of spines in a 20 μm segment from
three secondary apical dendrites of eachCA1neuronwere counted
using ImageJ.
PREPARATION OF HIPPOCAMPAL SLICES FOR ELECTROPHYSIOLOGICAL
RECORDING
The recording was performed as described previously (Cheng
et al., 2011; Hsu et al., 2011), with some modiﬁcations. Male
mice that were 8–12 weeks old and postnatal day 25–35 were
used for the theta-burst stimulation (TBS)-LTP and (S)-3,5-
dihydroxyphenylglycine (DHPG)-induced LTD studies, respec-
tively. The mice were decapitated, and their brains were isolated
by removing the skull with bone cutting forceps. The brains were
then immediately placed in ice-cold artiﬁcial cerebrospinal ﬂuid
(ACSF) for 3 min to lower the temperature before dissecting out
the hippocampus. ACSF is made with the following (in mM):
119 NaCl, 2.5 KCl, 1.3 MgSO4, 26.2 NaHCO3, 1 NaH2PO4,
2.5 CaCl2, and 11 glucose, pH adjusted to 7.4 and gassing
with 95% O2/5% CO. Transverse hippocampal slices (450 μm
thick) were made by vibrotome (MicroslicerTM DTK-1000, DKS).
The slices were kept in an interface-type holding chamber with
oxygenated ACSF (95% O2/5% CO2) at room temperature
(24–25◦C) and allowed to recover for at least 90 min before
recording.
EXTRACELLULAR FIELD POTENTIATION RECORDING
Brain slices were transferred to an immersion-type recording
chamber, perfused at 2 ml/min with ACSF containing 100 μM
picrotoxin at room temperature. An incision was made between
the CA1 and CA3 areas to remove afferent input from CA3. For
the extracellular ﬁeld potential recording, a glass pipette ﬁlled with
3 M NaCl was positioned in the CA1 stratum radiatum area to
record the ﬁeld excitatory post-synaptic potential (fEPSP). Bipo-
lar stainless steel stimulating electrodes (FHC, USA) were placed
in the striatum radiatum to stimulate the Schaffer collateral. Sta-
ble baseline fEPSP activity was recorded for at least 10 min by
applying a short-duration current stimulation pulse (∼40 μs) at
a predetermined intensity every 15 s. A TBS protocol, with four
pulses at 100 Hz in a burst and 10 bursts in a train, was deliv-
ered once for LTP induction. A paired-pulse stimulation (50 ms
intervals) at 1 Hz for 20 min (1200 trains) with D, L-AP5 applied
during recording was used to measure mGluR5-dependent LTD.
For paired-pulse facilitation, the stimulation intervals were in a
sequence of 50, 100, 200, 300, 500 and 30 ms, with an average of
20 traces. All of the signals were ﬁltered at 1 kHz using the low-pass
Bessel ﬁlter that was provided with the ampliﬁer, and the signals
were digitized at 10 kHz using aCEDmicro 1401 interface running
Signal software (Cambridge Electronic Design, Cambridge, UK).
The initial slopes of the fEPSPweremeasured for data analysis. The
synaptic responses were normalized to the average of the baseline.
The slope of the fEPSPs recorded during the last 10 min after a dif-
ferent pulse stimulation was averaged for statistical comparisons.
All data are presented as means ± SEMs. Statistical signiﬁcance
was tested by unpaired t-test. P < 0.05 was considered statistically
signiﬁcant.
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WHOLE-CELL RECORDING FOR THE NMDA/AMPA RATIO
Adult male hippocampal slices were cut perpendicularly to the
long axis in thickness of 300 μm for the whole-cell voltage-clamp
recordings. The slices were transferred to an immersion-type
recording chamber mounted on an upright microscope (BX50WI,
Olympus Optical Co., Ltd, Tokyo, Japan) equipped with 40x
water-immersionobjectives, aNomarski optic system, an infrared-
differential interference-contrast microscopy and a CCD camera
(Sony XC-EI50, Japan). The oxygenated ACSF was continuously
perfused at 1–2 ml/min. Recorded CA1 pyramidal neurons were
selected based on their morphology and location. The patch
pipettes pulled fromborosilicate glass tubing (1.5mmouter diam-
eter, 0.86 mm inner diameter; G150F-4, Warner Instruments)
had a resistance of 5–8 M when ﬁlled with internal solution
which consisting of the following (in mM): 131 K-gluconate, 20
KCl, 10 HEPES, 2 EGTA, 8 NaCl, 2 ATP, 0.3 GTP, and 6.7 bio-
cytin, with the pH adjusted to 7.2 by KOH and the osmolarity
to 300–305 mOsm. Recordings were made at room tempera-
ture (24–25◦C) with a patch ampliﬁer (Multiclamp 700 B; Axon
Instruments, Union City, CA, USA). For voltage-clamp record-
ings, the series resistance (Rs) was continuously monitored by
applying a voltage pulse of 1 mV and was not compensated for.
Data were discarded when the Rs varied by > 20% from its orig-
inal value during the recording. The membrane capacitance of
recorded neurons was 30.44 ± 3.22 pF for WT neurons and
36.06 ± 6.96 pF for Sarm1 knockdown neurons (n = 6). The
membrane resistance of recorded neuronswas 327.89± 41.70M
for WT neurons and 353.10 ± 54.44 M for Sarm1 knockdown
neurons (n = 6). All signals were low-pass ﬁltered at a cor-
ner frequency of 1 kHz and digitized at 10 kHz using a Micro
1401 interface (Cambridge ElectronicDesign). Datawere collected
using Signal software (Cambridge Electronic Design, Cambridge,
UK).
For the NMDAR/AMPAR ratio experiments, AMPAR-
mediated and NMDAR-mediated excitatory post-synaptic cur-
rents (EPSCs) were analyzed in two steps for each neuron. First,
the stable synaptic responses (EPSCs) were obtained by hold-
ing a neuron at −70 mV. The amplitude of these responses
was primarily generated by the α-Amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid (AMPA) receptor because the bath-
applied 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) in
ACSF completely blocked the current. Next, the holding potential
was changed to +40 mV to measure the synaptic responses medi-
ated by the NMDA receptors, which were later blocked by 50 μM
AP5 with CNQX perfusion. Twenty traces at each holding poten-
tial were averaged to analyze the current mediated by each speciﬁc
receptor. For the NMDA/AMPA ratio, AMPA or NMDA EPSCs
were measured by the amplitude of the peak current.
CHEMICALS AND TREATMENT IN THE ELECTROPHYSIOLOGY STUDY
The chemicals used for the ACSF and internal solutions were
purchased from Merck and Sigma. DL-APV, CNQX, picrotoxin,
DHPG, and CDPPB [3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)
benzamide] were purchased from Tocris. All of the drugs were
prepared in a high-concentration stock that was kept in an −80◦C
freezer. The chemicals were added to an ACSF bath prior to being
applied.
IMMUNOBLOTTING ANALYSIS
The entire hippocampus was homogenized with a pellet pes-
tle in lysis buffer containing 50 mM Tris (pH 7.4), 320 mM
sucrose, 2 mM dithiothreitol, 2 μg/ml leupeptin, 2 μg/ml
leupeptin, 2 μg/ml pepstatin-A, 2 μg/ml aprotinin, 1 mM
buffer tosylphenylalanylchloromethane, and 2 mM phenyl-
methylsulfonyl ﬂuoride and was then centrifuged at 800x g
for 10 min at 4◦C. The supernatant was boiled at 55◦C
in SDS sample buffer and separated by 7.5% or 10% SDS-
PAGE. After transfer, the membrane was treated with a
blocking solution (2.5% non-fat milk in 0.3% TBST) fol-
lowed by incubation with primary antibodies at 4◦C overnight.
The proteins were detected with HRP-conjugated goat sec-
ondary antibody and developed with Western Lightning Plus
ECL (PerkinElmer). The blot images were developed using
ImageQuantTM LAS 4000 (GE Health care Life Sciences, USA)
and X-ray ﬁlm (Fujiﬁm) without modiﬁcation of contrast or
brightness.
BEHAVIOR ANALYSIS
All of the animal experiments were carried out with the approval
of the Academia Sinica Institutional Animal Care and Utiliza-
tion Committee. Sarm1 knockdown mice were generated in a
C57BL/6J background (Chen et al., 2011). The animals used in
the behavioral assays were the offspring of transgenic males and
wild-type C57BL/6J females to eliminate any maternal effects of
Sarm1 knockdown on offspring behavior. Male littermate mice
were used in the behavioral assays to avoid variations due to the
estrus cycle. All of the procedures for the behavioral analyses have
been described previously (Chung et al., 2011; Lin and Hsueh,
2014), with minor modiﬁcations. The behavioral testing was per-
formed at 8–16 weeks of age. All of the animals were housed
in mixed-genotype groups of 3–5 mice per cage. The animals
were acclimatized to the test room for at least 1 week prior to
the behavioral assays. A 12 h light/dark cycle (lights off at 20:00)
was maintained in the test room. Food and water were accessed ad
libitum. For the reciprocal social interaction assays, each experi-
mentalmousewas independently housed for 1weekbefore the test.
The tests were performed between 14:00 and 19:00, prior to the
onset of the dark phase. For the rescue experiments, CDPPB was
dissolved in DMSO at a concentration of 14.6 mg/ml (40 mM),
and it was further diluted in polyethylene glycol-400 (PEG400,
Sigma) at a ratio of 1:8 to increase its solubility. Wild-type or
Sarm1 knockdown mice received an intraperitoneal (i.p.) injec-
tion of CDPPB at a dose of 10 mg/kg, or they received the same
volume of a DMSO-PEG400 mixture as a vehicle control. The
i.p. injections were performed six hours before the day 0 training
for contextual fear conditioning or reciprocal social interaction
to give sufﬁcient recovery time from the illness caused by viscous
PEG.
STATISTICAL ANALYSES
Unpaired t-tests were performed to analyze the differences
between WT and transgenic (Tg) animals using GraphPad Prism
5.0 (GraphPad Software, La Jolla, CA,USA). Two-wayANOVAwas
used to analyze Figure 6. For all comparisons, a P value < 0.05
was considered signiﬁcant.
Frontiers in Cellular Neuroscience www.frontiersin.org April 2014 | Volume 8 | Article 87 | 3
Lin et al. Sarm1 controls LTP and LTD
RESULTS
Sarm1 KNOCKDOWN LEADS TO HYPERSYNAPTIC RESPONSES UPON
GLUTAMATE STIMULATION IN HIPPOCAMPAL NEURONS
To investigate whether Sarm1 knockdown inﬂuences synaptic
function, Ca2+ imaging using cultured hippocampal neurons was
performed to monitor neuronal activity induced by glutamate
treatment. Theneuronswere transfectedwith a Sarm1knockdown
construct, Sarm1i (Chen et al., 2011), at DIV 6 and then subjected
to Ca2+ image recording at DIV 9. The Sarm1 knockdown con-
struct co-expresses green ﬂuorescence protein (GFP). Thus, the
GFP signal provides a marker for neuronal Sarm1 knockdown
and outlines neuronal morphology. We ﬁrst conﬁrmed that simi-
lar to previous ﬁndings (Chen et al., 2011), knockdown of Sarm1
impaired dendritic arborization (Figure 1A). The Ca2+ inﬂux
induced by glutamate stimulation was investigated in neurons that
were transfected with a vector control or Sarm1i at DIV 9 by mon-
itoring intracellular Ca2+ concentrations, as indicated by Fura-2.
After recording the baseline of intracellular calciumconcentration,
glutamate was added into the culture to induce calcium inﬂux
through NMDAR (Figure 1B). We found that compared the
calcium concentration before and after glutamate stimulation,
Sarm1 knockdown obviously induced more calcium inﬂux after
glutamate treatment (Figure 1C). The entire response was also
divided into three phases including baseline, rising and steady
phases (Figure 1B). For the baseline and rising phases, calcium
inﬂux was comparable between control and Sarm1 knockdown
neurons (Figure 1D). For the steady phase, the calcium con-
centration of Sarm1 knockdown neurons was noticeably higher
than that of control neurons. To make sure that the activation of
NMDAR does not induce cytotoxicity during recording, we also
monitored whether the calcium concentration is able to return
to the baseline after NMDAR activation and further respond to
calcium ionophore A23187 (Figure 1E). Indeed, the cultures were
still healthy after induction of NMDAR opening and were able to
return to the baseline and further respond to calcium ionophore
A23187 (Figure 1E). Taken together, the results of calcium imaging
FIGURE 1 | Sarm1 knockdown enhances Ca2+ influx after glutamate
treatment in cultured hippocampal neurons. (A) Representative images
of hippocampal neurons that have been transfected with a control vector
(Ctrl) or a Sarm1 shRNA expressing construct (Sarm1i). (B) Calcium imaging
after glutamate stimulation is shown. The Ca2+ signal in the soma was
monitored by Fura-2 for basal Ca2+ levels between 0 and 90 s. After
glutamate perfusion, a strong Ca2+ inﬂux response was induced, as shown
by the dramatic increase in the 340/380 ratio. The entire response was
separated into three phases (baseline, rising, and steady), as indicated.
(C) The ratio of 340/380 is shown. The means of the last 40 s (after glu)
and the ﬁrst 60 s (before glu) in (B) were calculated to determine the ratio
of 340/380 upon glutamate stimulation. (D) The summations of the
340/380 ratio of the baseline, rising and steady phases shown in (B).
(E) WT neurons were subjected to a series of treatments, as indicated.
After NMDA treatment, the calcium concentration was able to return to the
baseline and respond to calcium ionophore A23187 to cause calcium inﬂux.
The values represent the means ± SEMs. The sample sizes (n) are
indicated. *P < 0.05.
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indicated that neurons with Sarm1 knockdown had a higher
Ca2+ inﬂux after glutamate stimulation compared to the vector-
transfected control. The enhanced responses to neuronal stimula-
tion suggested that Sarm1 knockdown can change the synaptic
composition or the downstream signaling pathway following
stimulation.
Sarm1 KNOCKDOWN INCREASES THE SPINE DENSITY OF CA1
NEURONS AND ENHANCES NMDAR-DEPENDENT SYNAPTIC
PLASTICITY IN Sarm1 KNOCKDOWN MICE
Because spine morphology is linked with and changed by synap-
tic activity, we then examined whether Sarm1 deﬁciency alters
the morphology and density of dendritic spines of the CA1 neu-
rons. Golgi stain was used to analyze Sarm1 knockdown mice,
which were established previously (Chen et al., 2011). The results
showed that the dendritic spines of Sarm1 knockdown neurons
tended to be elongated in theirmorphology (Figure 2A). However,
the length and width of individual dendritic spines were immea-
surable because the spines were bunched together. Thus, we only
quantiﬁed thedensity of the dendritic spines. Thedata showed that
Sarm1 knockdown resulted in a higher density of dendritic spines
in CA1 neurons (Figures 2B,C). This increase in dendritic spine
density echoes the increase of calcium concentration in Sarm1
knockdown neurons after glutamate stimulation.
We then conducted a series of electrophysiology studies to
corroborate the involvement of Sarm1 in synaptic plasticity. An
extracellular ﬁeld recording in Schaffer collateral-CA1 synapses
was performed using acute hippocampal slices. We ﬁrst examined
the NMDAR-dependent LTP induced by TBS. Consistent with the
higher calcium inﬂux after glutamate stimulation and the higher
dendritic spine density, the fEPSPs of Sarm1 knockdown hip-
pocampal slices were enhanced by approximately 25% compared
FIGURE 2 | Sarm1 knockdown increases dendrite spine density in the
hippocampal CA1 region. (A)The representative images of CA1 neuronal
Golgi stains are shown. (B)The mean ( ± SEM) and (C) cumulative
probability of the numbers of dendritic spines were compared betweenWT
and Sarm1 knockdown CA1 neurons. The scale bars are set at 5 μm.The
sample sizes (n) of the dendrite number are indicated in the panels. The
data were collected from 15 to 19 neurons from 4WT to 4 Sarm1
knockdown mice, respectively. ***P < 0.001.
to the wild-type littermates (Figure 3A). It suggests that Sarm1
knockdown results in a hyper-LTP.
To dissect the origin of the disturbed NMDAR-dependent LTP,
paired-pulse stimulation was used to test the ability of presynaptic
terminals to release vesicles. The ratio of paired-pulse stimula-
tion indicated that vesicle release was comparable between Sarm1
knockdown and wild type neurons (Figure 3B). It suggests that
Sarm1 knockdown hippocampi have normal presynaptic func-
tion. We then analyzed the relative contribution of the NMDA
and AMPA receptors to the EPSCs that were evoked by stim-
ulation from the Schaffer collateral afferent. We found that the
NMDA/AMPA ratio was signiﬁcantly increased in Sarm1 knock-
downneurons (Figure 3C). Taken together, these data indicate that
reduced Sarm1 expression affects the synaptic response through
a post-synaptic mechanism, which regulates the conductivity of
NMDAR and AMPAR.
We also analyzed the composition of synaptic proteins by iso-
lating crude synaptosomal fractions (P2) from adult wild type
and Sarm1 knockdown hippocampi. The results showed that
the expression levels of presynaptic proteins, including synapsin,
synaptotagmin, SVP38, NSF and Munc18, were not altered
(Figure 4A), echoing the normal paired-pulse facilitation in
Sarm1 knockdown brains. The only signiﬁcant differences were
the expression of post-synaptic scaffold proteins and NMDA
receptor subunits, including Shank1, Shank3, NR1, and NR2a
(Figures 4B,C). The increases were small (∼12–25%) but sig-
niﬁcant. These changes of post-synaptic protein levels provide
a potential molecular explanation for hyper-NMDAR-dependent
LTP in Sarm1 knockdown mice.
Sarm1 KNOCKDOWN ALSO RESULTS IN IMPAIRED mGluR-DEPENDENT
LTD
In addition to NMDAR-dependent LTP, we investigated LTD
in the Sarm1 knockdown hippocampus. We were interested in
the mGluR-dependent LTD because its involvement in synap-
tic pathophysiology has been conﬁrm in two syndromic forms
of autism with intellectual disability, tuberous sclerosis complex
(TSC1+/−, TSC2+/−) and fragile X syndrome (Fmr1−/−; Bear
et al., 2004; Zoghbi and Bear, 2012). Activation of mGluR triggers
rapid local translation of proteins required for the endocytosis of
AMPA receptors. This activity reduces the surface expression of
AMPA receptors and leads to the formation of mGluR-induced
LTD. Because Sarm1 has been shown to inﬂuence the ASK1-
MKK-JNK/p38 pathway in neurons (Chuang and Bargmann,
2005; Chen et al., 2011), which is required for mGluR down-
stream signaling (Li et al., 2007; Moult et al., 2008), we asked
whether Sarm1 could also participate in the synaptic activity
that was regulated by mGluR. Two independent protocols were
used to measure mGluR-LTD, including chemically and electri-
cally induced LTD, either by treating with DHPG, an agonist of
group I mGluR, or by paired pulse-low frequency stimulation
(PP-LFS). The results of both experiments indicated that none
of stimulations was able to induce LTD in Sarm1 knockdown
brains, because compared to a wild-type control, Sarm1 knock-
down brains exhibited a greatly reduced magnitude of DHPG-
and PP-LFS-induced LTD in the hippocampus (Figures 5A,B).
To conﬁrm that the deﬁciency of mGluR signaling in Sarm1
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FIGURE 3 | Sarm1 knockdown enhances NMDAR-dependent LTP in
hippocampi. (A)Theta burst stimulation-induced LTP was recorded in the
hippocampal CA1 region. The fEPSPs were recording in the CA1 and plotted
against time. The representative traces shown at the top are an average of 40
fEPSPs from the baseline (1) and the last 10 min of recording (2). Each trace is
the average of 40 fEPSPs from the baseline. The last 10 min of recording are
further subjected for quantitative analysis. The horizontal dashed lines indicate
the average value of the normalized amplitude during the baseline period.
Calibration: 0.2 mV, 10 msec. The histogram summarizing the average fEPSP
of the last 10 min of recording is shown in the right panel. The data represent
the mean plus SEM (for histograms) or ± SEM (for fEPSP slope). *P < 0.05.
(B)The paired-pulse facilitation was similar between Sarm1 knockdown and
WT mice. The data represent the mean ± SEM. (C)The representative
NMDAR (indicated by the gray line) and AMPAR (indicated by the black line)
mediated currents fromWT and Sarm1 knockdown CA1 neurons are shown
in the upper panel. The ratio of NMDA to AMPA current is shown in the lower
panel. The data indicate the mean plus SEM. *P < 0.05. The sample sizes (n)
are indicated.
knockdown mice, CDPPB, was added prior to the administration
of DHPG. CDPPB functions as a positive allosteric modulator
of mGluR5, which facilitates the effect of DHPG on mGluR.
Thus, if the defect of Sarm1 knockdown neurons in response to
DHPG is due to the deﬁcit of mGluR signaling, the treatment
of CDPPB is expected to rescue the defects in LTD (Auerbach
et al., 2011; Verpelli et al., 2011). Indeed, enhancing mGluR5 sig-
naling by CDPPB reversed the LTD defect in Sarm1 knockdown
(Figure 5C). It conﬁrmed that the deﬁcits in mGluR5 signal-
ing were involved in the LTD impairment of Sarm1 knockdown
mice.
CDPPB TREATMENT AMELIORATES THE BEHAVIORAL DEFECTS IN
Sarm1 KNOCKDOWN MICE
A recent study that focused on fragile X and tuberous sclerosis
mouse models suggests that there is shared synaptic pathol-
ogy in mGluR signaling (Auerbach et al., 2011). In particular,
TSC2+/− mutant mice display reduced mGluR-LTD responses,
which are associated with intellectual disabilities, and these symp-
toms can be improved by enhancing mGluR signaling (Auerbach
et al., 2011). Because Sarm1 knockdown mice are characterized
by autistic phenotypes (Lin and Hsueh, 2014) and because the
data above showed an impairment of mGluR-dependent LTD
in Sarm1 knockdown mice, we asked whether a pharmacolog-
ical treatment could reverse the defects in Sarm1 knockdown
mice, speciﬁcally dysregulated mGluR-dependent LTD and behav-
ioral defects. Reciprocal social interaction and contextual fear
conditioning were examined. We have previously demonstrated
that Sarm1 knockdown affects these two behavior paradigms
in mice (Lin and Hsueh, 2014). CDPPB was injected i.p. into
Sarm1 knockdown and WT littermate mice prior to the behav-
ioral assays (Figures 6A,B). Consistent with the effects of CDPPB
on electrophysiology (Figure 4C), we found that the systemic
administration of CDPPB also ameliorated the behavioral defects
observed in Sarm1 knockdown mice during contextual fear condi-
tioning (Figure 6A) and reciprocal social interaction (Figure 6B).
These results strengthen the link between mGluR-dependent LTD
and Sarm1-regulated neuronal function, and they provide a possi-
ble treatment to ameliorate the behavioral defects caused by Sarm1
deﬁciency.
DISCUSSION
In this report, we demonstrate that Sarm1 knockdown causes
synaptic dysfunction, including increased Ca2+ inﬂux upon
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FIGURE 4 | Expression of some synaptic proteins are altered in Sarm1
knockdown mice. (A) Presynaptic proteins. (B) Post-synaptic protein.
(C) Glutamate receptors. The synaptosomal fractions of the hippocampi
were analyzed by immunoblotting with antibodies, as indicated. Five
animals for each genetic background were used for analysis. The data
represent the mean ± SEM normalized to theWT levels. *P < 0.05.
glutamate treatment in vitro as well as enhanced NMDAR-
dependent LTP and impaired mGluR-dependent LTD in hip-
pocampi. The behavioral rescue by CDPPB, a positive allosteric
modulator of mGluR, further supports a role for mGluR signal-
ing in the pathogenesis of autistic-like behaviors that are caused
by Sarm1 knockdown. Metobotrophic GluR signaling activity is
known to mediate spine shrinkage and degradation (Oh et al.,
2013; Ramiro-Cortes and Israely, 2013), which may account for
the increased spine density thatwas observed in theCA1pyramidal
neurons. Our data also suggest that there are changes in post-
synaptic protein composition, including NR1, NR2a, and Shank
FIGURE 5 | Metabotropic GluR-dependent LTD is defective in the
Sarm1 knockdown hippocampus. Chemically and electrically induced
LTD were recorded in the hippocampal CA1. The fEPSP is shown plotted as
a function of time, and the representative traces at the indicated time
points (labeled by 1 and 2 in the ﬁgure) are shown above. mGluR-
dependent LTD induced by (A) DHPG and (B) paired-pulse low frequency
stimulation was impaired in Sarm1 knockdown brains. (C) CDPPB was bath
applied from the baseline recording for 25 min and showed profound
rescue of DHPG-induced LTD in the Sarm1 knockdown hippocampus.
(A–C)The horizontal dashed lines indicate the average value of the
normalized amplitude during the control period. Calibration: 0.2 mV,
10 msec. For both LTP and LTD, histograms summarizing the average of the
fEPSPs of the last 10 min of recording are shown in the right panels. The
data represent the mean plus SEM (for histograms) or ± SEM (for fEPSP
slopes). The sample sizes (n) are indicated. *P < 0.05; ns, not signiﬁcant.
proteins, in Sarm1 knockdown brains. These synaptic proteins not
only directly contribute to synaptic responses but are also known
to be involved in the etiology of autism spectrum disorder (ASD).
For example, all of the members of the Shank protein family that
indirectly link NMDAR and mGluR were identiﬁed as autism
causative genes (Durand et al., 2007; Hung et al., 2008; Berkel
et al., 2010; Pinto et al., 2010; Peca et al., 2011; Sato et al., 2012;
Schmeisser et al., 2012; Won et al., 2012). Mutations in the NR2b
gene were consistently identiﬁed in patients with autism (O’Roak
et al., 2012). These observations support the current hypothesis
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FIGURE 6 | Enhancement of mGluR5 signaling ameliorates the behav-
ioral defects in Sarm1 knockdown mice. CDPPB (10 mg/kg of animal body
weight) or a vehicle control was intraperitonally injected into mice six hours
before the behavioral assay. (A)The results of contextual fear conditioning are
shown. (B)The results of reciprocal social interaction are shown. CDPPB did
not obviously inﬂuence the behaviors ofWT littermates. However, CDPPB
rescued the defects observed in Sarm1 knockdown mice. The sample sizes
(n) are indicated in the column. *P < 0.05; ns, not signiﬁcant.
that the intellectual disabilities associated with autism are caused
by unbalanced synaptic activity. Both overly strong or overly weak
synaptic function can harmneural plasticity and results in autistic-
like behaviors and impaired intellectual performance (Auerbach
et al., 2011; Sui and Chen, 2012; Zoghbi and Bear, 2012; Lin et al.,
2013; Nuytens et al., 2013). However, the detailed mechanisms
underlying the role of Sarm1 in LTD and LTP have yet to be
determined. For example, it will be intriguing to further elucidate
whether Sarm1 regulates mGluR and NMDAR signaling through
independent mechanisms or primarily through an effect on the
mGluR pathway that modulates the NMDAR response indirectly.
Because Shank proteins were upregulated in Sarm1 knockdown
neurons and because Shanks link NMDAR to mGluR, Sarm1
knockdown may also inﬂuence both NMDAR and mGluR via
Shanks.
Based on previous studies, Sarm1 likely regulates synaptic
plasticity through both direct and indirect mechanisms. Our
previous study showed that Sarm1 is widely distributed in dif-
ferent neuronal subcellular regions, including in the synapses
(Chen et al., 2011). Sarm1 puncta were partially co-localized
with PSD-95 (Chen et al., 2011). The synaptic localization of
Sarm1 can be maintained by direct interaction with syndecan-
2, a transmembrane heparan sulfate proteoglycan that is highly
enriched at the synapse. Synaptic Sarm1 may recruit signaling
molecules, such as the components of the MKK4-JNK pathway,
to synapses. In C. elegans, the synaptic localization of Tir-1, a
Sarm1 homolog, is determined by the interaction between its SAM
domain and UNC-43 (CaMKII homolog; Chuang and Bargmann,
2005). In mammalian neurons, CaMKII is also a key component
in synaptic plasticity, and it is concentrated at the post-synaptic
region (Lisman et al., 2002; Lee et al., 2009). It seems likely that
Sarm1 also interacts directly with CaMKII to control synaptic
plasticity.
Sarm1 also regulates neuronal morphogenesis (Chen et al.,
2011) and the expression of inﬂammatory cytokines in the
brain (Lin et al., 2014). In addition to dendritic arborization
and axonal differentiation, we showed here that Sarm1 knock-
down can also inﬂuence dendritic spine density. Because proper
neuronal morphology is essential for effective communication
between neurons, the abnormalities of neuronal morphology
caused by Sarm1 knockdown may result in dysregulated circuits
between hippocampal CA1 and CA3, thus impairing synap-
tic plasticity in Sarm1 knockdown mice. On the other hand,
Sarm1 knockdown causes dysregulated cytokine expression in
the brain, including changes in IL-1β, IL-12, CCL5, TNF-
α ,and IFN-β production (Lin et al., 2014). IL-1ß and TNF-α
are known to regulate synaptic plasticity (Del Rey et al., 2013;
Gruber-Schoffnegger et al., 2013). Thus, it is also likely that
inﬂammatory cytokines mediate Sarm1 effects on synaptic plas-
ticity.
In the rescue experiments, CDPPB treatment was able to
ameliorate the behavioral defects found in the Sarm1 knock-
down mice, suggesting a critical role for mGluR signaling in
the Sarm1 pathway. Because of the function of Sarm1 in innate
immune responses, our data also reveals a potential treatment
for inﬂammation-related neurological disorders by using mGluR
agonists.
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